Open AccessRituximab for autoimmune retinopathy: Results of a Phase I/II clinical trial
Author(s) -
Karen R Armbrust,
Austin Fox,
Brett G. Jeffrey,
Patti Sherry,
H. Nida Sen
Publication year - 2021
Publication title -
taiwan journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.519
H-Index - 9
eISSN - 2211-5072
pISSN - 2211-5056
DOI - 10.4103/tjo.tjo_32_20
Subject(s) - medicine , rituximab , adverse effect , clinical trial , prospective cohort study , phases of clinical research , surgery , lymphoma
This prospective study evaluates whether rituximab is a safe and potentially effective treatment for nonparaneoplastic autoimmune retinopathy (npAIR).